Regulation of GIP and Ghrelin in Healthy Subjects Fed on Sun-Dried Raisins: A Pilot Study with a Crossover Trial Design

Journal of Medicinal Food

Volumn 20, Issue 3, 2017, Pages 301-308

  Kaliora, Andriana C ^a   Kanellos, Panagiotis T ^a   Gioxari, Aristea ^a   Karathanos, Vaios T ^a  

^a HAROKOPIO UNIVERSITY   (Greece)

Author keywords

Antioxidants; Fructose; Glucose metabolism; Polyphenols

Indexed keywords

APELIN; GASTRIC INHIBITORY POLYPEPTIDE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; OBESTATIN; GLUCOSE BLOOD LEVEL;

ADULT; APPETITE; ARTICLE; BODY MASS; CROSSOVER PROCEDURE; DIETARY FIBER; GLUCOSE BLOOD LEVEL; GRAPE; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; NORMAL HUMAN; PILOT STUDY; POSTPRANDIAL STATE; PRIORITY JOURNAL; REGULATORY MECHANISM; WAIST CIRCUMFERENCE; CHEMISTRY; CONTROLLED STUDY; FEMALE; MALE; METABOLISM; RANDOMIZED CONTROLLED TRIAL; VITIS; YOUNG ADULT;

ADULT; APPETITE; BLOOD GLUCOSE; CROSS-OVER STUDIES; FEMALE; GASTRIC INHIBITORY POLYPEPTIDE; GHRELIN; GLUCAGON-LIKE PEPTIDE 1; HEALTHY VOLUNTEERS; HUMANS; INSULIN; MALE; PILOT PROJECTS; POSTPRANDIAL PERIOD; VITIS; YOUNG ADULT;

EID: 85015688822     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2016.0123     Document Type: Article

References (53)

1. Vilsbøll T, Krarup T, Madsbad S, Holst JJ: Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects. Regul Pept 2003;114:115-121.
2. Nauck MA, Homberger E, Siegel EG, Allen RC, Eaton RP, Ebert R, Creutzfeldt W: Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses. J Clin Endocrinol Metab 1986;63:492-498.
3. Holst JJ: The physiology of glucagon-like peptide 1. Physiol Rev 2007;87:1409-1439.
4. Verdich C, Flint A, Gutzwiller JP, Näslund E, Beglinger C, Hellström PM, Long SJ, Morgan LM, Holst JJ, Astrup A: A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. J Clin Endocrinol Metab 2001;86:4382-4389.
5. Vilsbøll T, Christensen M, Junker AE, Knop FK, Gluud LL: Effects of glucagon-like peptide-1 receptor agonists on weight loss: Systematic review and meta-analyses of randomised controlled trials. BMJ 2012;344:d7771.
6. Kong MF, Chapman I, Goble E, Wishart J, Wittert G, Morris H, Horowitz M: Effects of oral fructose and glucose on plasma GLP-1 and appetite in normal subjects. Peptides 1999;20:545-551.
7. Rayner CK, Park HS, Wishart JM, Kong M, Doran SM, Horowitz M: Effects of intraduodenal glucose and fructose on antropyloric motility and appetite in healthy humans. Am J Physiol Regul Integr Comp Physiol 2000;278:R360-R366.
8. Gualillo O, Lago F, Casanueva FF, Dieguez C: One ancestor, several peptides post-translational modifications of preproghrelin generate several peptides with antithetical effects. Mol Cell Endocrinol 2006;256:1-8.
9. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402:656-660.
10. van der Lely AJ: Ghrelin and new metabolic frontiers. Horm Res 2009;71(suppl):129-133.
11. Gasco V, Beccuti G, Marotta F, Benso A, Granata R, Broglio F, Ghigo E: Endocrine and metabolic actions of ghrelin. Endocr Dev 2010;17:86-95.
12. Granata R, Baragli A, Settanni F, Scarlatti F, Ghigo E: Unraveling the role of the ghrelin gene peptides in the endocrine pancreas. J Mol Endocrinol 2010;45:107-118.
13. Lim CT, Kola B, Korbonits M, Grossman AB: Ghrelin's role as a major regulator of appetite and its other functions in neuroendocrinology. Prog Brain Res 2010;182:189-205.
14. Tannous dit El Khoury D, Obeid O, Azar ST, Hwalla N: Variations in postprandial ghrelin status following ingestion of highcarbohydrate, high-fat, and high-protein meals in males. Ann Nutr Metab 2006;50:260-269.
15. Zhang JV, Ren PG, Avsian-Kretchmer O, Luo CW, Rauch R, Klein C, Hsueh AJ: Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 2005;310: 996-999.
16. Zizzari P, Longchamps R, Epelbaum J, Bluet-Pajot MT: Obestatin partially affects ghrelin stimulation of food intake and growth hormone secretion in rodents. Endocrinology 2007;148: 1648-1653.
17. Nogueiras R, Pfluger P, Tovar S, Arnold M, Mitchell S, Morris A, Perez-Tilve D, Vázquez MJ, Wiedmer P, Castanẽda TR, Di-Marchi R, Tschöp M, Schurmann A, Joost HG, Williams LM, Langhans W, Diéguez C: Effects of obestatin on energy balance and growth hormone secretion in rodents. Endocrinology 2007; 148:21-26.
18. Sedlácková D, Kopecková J, Papezová H, Vybral S, Kvasnicková H, Hill M, Nedvdková J: Changes of plasma obestatin, ghrelin and NPY in anorexia and bulimia nervosa patients before and after a high-carbohydrate breakfast. Physiol Res 2011;60: 165-173.
19. Lee DK, Cheng R, Nguyen T, Fan T, Kariyawasam AP, Liu Y, Osmond DH, George SR, O'Dowd BF: Characterization of apelin, the ligand for the APJ receptor. J Neurochem 2000;74: 34-41.
20. Tatemoto K, Takayama K, Zou MX, Kumaki I, Zhang W, Kumano K, Fujimiya M: The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Pept 2001; 99:87-92.
21. Boucher J, Masri B, Daviaud D, Gesta S, Guigné C, Mazzucotelli A, Castan-Laurell I, Tack I, Knibiehler B, Carpéné C, Audigier Y, Saulnier-Blache JS, Valet P: Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 2005; 146:1764-1771.
22. Sunter D, Hewson AK, Dickson SL: Intracerebroventricular injection of apelin-13 reduces food intake in the rat. Neurosci Lett 2003;353:1-4.
23. O'Shea M, Hansen MJ, Tatemoto K, Morris MJ: Inhibitory effect of apelin-12 on nocturnal food intake in the rat. Nutr Neurosci 2003;6:163-167.
24. Taheri S, Murphy K, Cohen M, Sujkovic E, Kennedy A, Dhillo W, Dakin C, Sajedi A, Ghatei M, Bloom S: The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats. Biochem Biophys Res Commun 2002;291: 1208-1212.
25. Paschetta E, Hvalryg M, Musso G: Glucose-dependent insulinotropic polypeptide: From pathophysiology to therapeutic opportunities in obesity-associated disorders. Obes Rev 2011;12: 813-828.
26. Song DH, Wolfe MM: Glucose-dependent insulinotropic polypeptide and its role in obesity. Curr Opin Endocrinol Diabetes Obes 2007;14:46-51.
27. Johnston KL, Clifford MN, Morgan LM: Possible role for apple juice phenolic compounds in the acute modification of glucose tolerance and gastrointestinal hormone secretion in humans. J Sci Food Agric 2002;82:1800-1805.
28. Sykes S, Morgan LM, English J, Marks V: Evidence for preferential stimulation of gastric inhibitory polypeptide secretion in the rat by actively transported carbohydrates and their analogues. J Endocrinol 1980;85:201-207.
29. Chiou A, Karathanos VT, Mylona A, Salta FN, Preventi F, Andrikopoulos NK: Currants (Vitis vinifera L.) content of simple phenolics and antioxidant activity. Food Chem 2007;102:516-522.
30. Kanellos PT, Kaliora AC, Gioxari A, Christopoulou GO, Kalogeropoulos N, Karathanos VT: Absorption and bioavailability of antioxidant phytochemicals and increase of serum oxidation resistance in healthy subjects following supplementation with raisins. Plant Foods Hum Nutr 2013;68:411-415.
31. Wölnerhanssen BK, Meyer-Gerspach AC, Schmidt A, Zimak N, Peterli R, Beglinger C, Borgwardt S: Dissociable behavioral, physiological and neural effects of acute glucose and fructose ingestion: A pilot study. PLoS One 2015;10:e0130280.
32. Garća-Rodŕguez CE, Mesa MD, Olza J, Buccianti G, Pérez M, Moreno-Torres R, Pérez de la Cruz A, Gil A: Postprandial glucose, insulin and gastrointestinal hormones in healthy and diabetic subjects fed a fructose-free and resistant starch type IV-enriched enteral formula. Eur J Nutr 2013;52:1569-1578.
33. Deacon CF, Johnsen AH, Holst JJ: Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo. J Clin Endocrinol Metab 1995;80:952-957.
34. Hoggard N, Cruickshank M, Moar KM, Bestwick C, Holst JJ, Russell W, Horgan G: A single supplement of a standardised bilberry (Vaccinium myrtillus L.) extract (36% wet weight anthocyanins) modifies glycaemic response in individuals with type 2 diabetes controlled by diet and lifestyle. J Nutr Sci 2013;2:e22.
35. Barone Lumaga R, Azzali D, Fogliano V, Scalfi L, Vitaglione P: Sugar and dietary fibre composition influence, by different hormonal response, the satiating capacity of a fruit-based and a bglucan-enriched beverage. Food Funct 2012;3:67-75.
36. Kanellos PT, Kaliora AC, Liaskos C, Tentolouris NK, Perrea D, Karathanos VT: A study of glycemic response to Corinthian raisins in healthy subjects and in type 2 diabetes mellitus patients. Plant Foods Hum Nutr 2013;68:145-148.
37. Kanellos PT, Kaliora AC, Tentolouris NK, Argiana V, Perrea D, Kalogeropoulos N, Kountouri AM, Karathanos VT: A pilot, randomized controlled trial to examine the health outcomes of raisin consumption in patients with diabetes. Nutrition 2014;30: 358-364.
38. Eelderink C, Schepers M, Preston T, Vonk RJ, Oudhuis L, Priebe MG: Slowly and rapidly digestible starchy foods can elicit a similar glycemic response because of differential tissue glucose uptake in healthy men. Am J Clin Nutr 2012;96:1017-1024.
39. Ludwig DS: The glycemic index: Physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA 2002; 287:2414-2423.
40. Kallio P, Kolehmainen M, Laaksonen DE, Pulkkinen L, Atalay M, Mykkänen H, Uusitupa M, Poutanen K, Niskanen L: Inflammation markers are modulated by responses to diets differing in postprandial insulin responses in individuals with the metabolic syndrome. Am J Clin Nutr 2008;87:1497-1503.
41. Kallio P, Kolehmainen M, Laaksonen DE, Kekäläinen J, Salopuro T, Sivenius K, Pulkkinen L, Mykkänen HM, Niskanen L, Uusitupa M, Poutanen KS: Dietary carbohydrate modification induces alterations in gene expression in abdominal subcutaneous adipose tissue in persons with the metabolic syndrome: The FUNGENUT Study. Am J Clin Nutr 2007;85: 1417-1427.
42. Foster-Schubert KE, Overduin J, Prudom CE, Liu J, Callahan HS, Gaylinn BD, Thorner MO, Cummings DE: Acyl and total ghrelin are suppressed strongly by ingested proteins, weakly by lipids, and biphasically by carbohydrates. J Clin Endocrinol Metab 2008;93:1971-1979.
43. Teff KL, Elliott SS, Tschöp M, Kieffer TJ, Rader D, Heiman M, Townsend RR, Keim NL, D'Alessio D, Havel PJ: Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. J Clin Endocrinol Metab 2004;89:2963-2972.
44. Teff KL, Grudziak J, Townsend RR, Dunn TN, Grant RW, Adams SH, Keim NL, Cummings BP, Stanhope KL, Havel PJ: Endocrine and metabolic effects of consuming fructoseand glucose-sweetened beverages with meals in obese men and women: Influence of insulin resistance on plasma triglyceride responses. J Clin Endocrinol Metab 2009;94:1562-1569.
45. Stanhope KL, Griffen SC, Bair BR, Swarbrick MM, Keim NL, Havel PJ: Twenty-four-hour endocrine and metabolic profiles following consumption of high-fructose corn syrup-, sucrose-,fructose-, and glucose-sweetened beverages with meals. Am J Clin Nutr 2008;87:1194-1203.
46. Furchner-Evanson A, Petrisko Y, Howarth L, Nemoseck T, Kern M: Type of snack influences satiety responses in adult women. Appetite 2010;54:564-569.
47. Nilsson AC, Ostman EM, Holst JJ, Björck IM: Including indigestible carbohydrates in the evening meal of healthy subjects improves glucose tolerance, lowers inflammatory markers, and increases satiety after a subsequent standardized breakfast. J Nutr 2008;138:732-739.
48. St-Pierrea P, Pilona G, Dumaisa V, Diona C, Duboisa M-J, Dubéb P, Desjardinsb Y, Marette A: Comparative analysis of maple syrup to other natural sweeteners and evaluation of their metabolic responses in healthy rats. J Funct Foods 2014;11:460-471.
49. Puglisi MJ, Mutungi G, Brun PJ, McGrane MM, Labonte C, Volek JS, Fernandez ML: Raisins and walking alter appetite hormones and plasma lipids by modifications in lipoprotein metabolism and up-regulation of the low-density lipoprotein receptor. Metabolism 2009;58:120-128.
50. Gruendel S, Garcia AL, Otto B, Mueller C, Steiniger J, Weickert MO, Speth M, Katz N, Koebnick C: Carob pulp preparation rich in insoluble dietary fiber and polyphenols enhances lipid oxidation and lowers postprandial acylated ghrelin in humans. J Nutr 2006;136:1533-1538.
51. Gruendel S, Garcia AL, Otto B, Wagner K, Bidlingmaier M, Burget L, Weickert MO, Dongowski G, Speth M, Katz N, Koebnick C: Increased acylated plasma ghrelin, but improved lipid profiles 24-h after consumption of carob pulp preparation rich in dietary fibre and polyphenols. Br J Nutr 2007;98:1170-1107.
52. Qi X, Li L, Yang G, Liu J, Li K, Tang Y, Liou H, Boden G: Circulating obestatin levels in normal subjects and in patients with impaired glucose regulation and type 2 diabetes mellitus. Clin Endocrinol (Oxf) 2007;66:593-597.
53. Huda MSB, Durham BH, Wong SP, Deepak D, Kerrigan D, McCulloch P, Ranganath L, Pinkney J, Wilding JPH: Plasma obestatin levels are lower in obese and postgastrectomy subjects, but do not change in response to a meal. Int J Obes (Lond) 2008; 32:129-135.